USA Exclusive Patent License for Research to Develop New Drugs

Grant other parties the right to use your medical patents in order to research, develop, market and sell new pharmaceutical drugs in the USA with this Exclusive Patent License Agreement.

• The party being granted the license (licensee) has the exclusive right to manufacture, use and sell the products within a defined territory and for use within a defined field of medicine.
• The licensee's rights are subject to timely payment of all amounts due from the licensee to the licensor, and subject to the licensor's rights to use and transfer the materials for academic or research purposes.
• The licensee will pay the licensor an annual licensing fee and a minimum yearly royalty, as well as a continuing royalty calculated based on the net sales of products within the territory.
• The licensee will also pay milestone fees upon the initiation of each phase of clinical studies.
• If the licensed materials were developed under a funding agreement with the United States government, the license is granted subject to any rights the government has in the materials.
• Mutual confidentiality obligations between the parties.

This USA Exclusive Patent License for Research to Develop New Drugs is provided in MS Word format, and is fully editable to fit your specific circumstances.